You have 9 free searches left this month | to do more

paclitaxel

Paclitaxel is a drug used to treat Breast Cancer, Ovarian Cancer, Lung Cancer, and other conditions. Paclitaxel is being actively studied in 536 studies and prior, has been studied in 879.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Fox Chase Cancer CenterZefen Xiao
Hoffmann-La RocheUniversity of Oklahoma Health Sciences CenterZhimin Shao
M.D. Anderson Cancer CenterWashington University School of MedicineH.W.M. van Laarhoven
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Effect of Albumin-bound Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian, Fallopian Tube or Peritoneal Cancer: A Phase 2 Single Center Clinical Trial
Not yet recruiting
  • Ovarian Cancer
  • albumin-bound paclitaxel
  • paclitaxel
  • (no location specified)
2022-03-31
Mar 31, 2022
C
Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
2022-03-17
Mar 17, 2022
C
Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Recruiting
  • Ovarian Cancer
  • +3 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
2022-03-07
Mar 7, 2022
S
A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer - 2017
Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +4 more
2022-04-04
Apr 4, 2022
U
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer
Recruiting
  • Breast Cancer
  • Paclitaxel
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2022-02-01
Feb 1, 2022
U
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
Active, not recruiting
  • Breast Neoplasm Female
  • Paclitaxel
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-01-10
Jan 10, 2022
U
Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
Active, not recruiting
  • Breast Cancer
  • +3 more
  • Including Dallas And Austin, Texas
    22 Sites
2021-12-03
Dec 3, 2021
W
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Recruiting
  • Cutaneous Angiosarcoma
  • Paclitaxel
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-25
May 25, 2021
S
A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer
Recruiting
  • Triple-Negative Breast Cancer
  • Kaohsiung, Taiwan
  • +5 more
2022-02-18
Feb 18, 2022
A
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel
Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +2 more
2022-03-02
Mar 2, 2022
N
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, (DURVA+ Study)
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Bethesda, Maryland
    National Cancer Institute Developmental Therapeutics Clinic
2022-03-17
Mar 17, 2022
S
Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis
Recruiting
  • Stomach Neoplasms
  • +2 more
  • Paclitaxel
  • Seoul, Korea, Republic of
    Gastric cancer center, Seoul St. Mary's Hospital
2021-07-01
Jul 1, 2021
A
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
Active, not recruiting
  • Breast - Female
  • Male Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-12-14
Dec 14, 2021
D
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer
Active, not recruiting
  • Advanced Gastric Cancer
  • Paclitaxel
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-09-22
Sep 22, 2021
U
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
2022-01-28
Jan 28, 2022
S
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
Recruiting
  • Solid Tumor
  • Stomach Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
2021-08-21
Aug 21, 2021
A
Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients
Active, not recruiting
Has Results
  • Gastric Cancer
  • Anyang, Korea, Republic of
  • +13 more
2022-04-05
Apr 5, 2022
W
Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
Active, not recruiting
  • Transitional Cell Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
2021-08-30
Aug 30, 2021
E
Safety, Tolerability and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced GC or GEJ Cancer.
Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
2021-09-03
Sep 3, 2021
H
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
Active, not recruiting
Has Results
  • Ovarian Cancer
  • Tampa, Florida
  • +2 more
2022-03-17
Mar 17, 2022
W
Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
Recruiting
  • Gastric Cancer
  • +4 more
  • Wuhan, Hubei, China
    Wuhan Union Hospital
2022-02-18
Feb 18, 2022
N
Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC
Active, not recruiting
  • Head and Neck Cancer
  • Singapore, Singapore
    National Cancer Centre - Singapore
2021-09-06
Sep 6, 2021
A
A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer
Active, not recruiting
  • Advanced Breast Cancer
  • Ribociclib (LEE011)
  • Paclitaxel
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-10-28
Oct 28, 2021
E
Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France
No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
2022-04-06
Apr 6, 2022
T
Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer - 2021
Completed
  • Solid Tumor, Adult
  • EOC202
  • Paclitaxel
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-03-30
Mar 30, 2022